Accrued Expenses and Other Liabilities (Tables)

6 Months Ended

Jun. 30, 2024

Accrued Expenses and Other Liabilities

Schedule of accrued expenses and other liabilities

	June 30,		December 31,
	2024		2023
Accrued marketing expenses	$	1,021,563	$	1,013,497
Other expenses		310,603		313,254
Accrued preclinical and clinical trial expenses		364,460		405,792
Compensation and related benefits		543,574		332,641
Accrued manufacturing expenses		18,915		97,877
Advance payments received from customers for manufacturing materials		476,288		—
Accrued franchise tax		—		38,800
	$	2,735,403	$	2,201,861